Cancer risks in ulcerative colitis patients

International Journal of Cancer

Volumn 123, Issue 6, 2008, Pages 1417-1421

  Hemminki, Kari ^a,b   Li, Xinjun ^b   Sundquist, Jan ^b   Sundquist, Kristina ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Age at hospitalization; Autoimmunity; Cancer risk; Inflammatory bowel disease

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST TUMOR; CALCULATION; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CARCINOID; CHRONIC MYELOID LEUKEMIA; COLON CANCER; DATA BASE; DISEASE ASSOCIATION; ENDOCRINE TUMOR; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PANCREAS CANCER; PANCREAS TUMOR; PATIENT IDENTIFICATION; PERIODIC MEDICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; RISK ASSESSMENT; SMALL INTESTINE TUMOR; TUMOR LOCALIZATION; ULCERATIVE COLITIS;

ADULT; AGED; COLITIS, ULCERATIVE; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; RISK FACTORS; SWEDEN;

EID: 49749123928     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23666     Document Type: Article

References (26)

1. Schreiber S, Rosenstiel P, Albrecht M, Hampe J, Krawczak M. Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet 2005;6:376-88.
2. Orholm M, Fonager K, Sorensen HT. Risk of ulcerative colitis and Crohn's disease among offspring of patients with chronic inflammatory bowel disease. Am J Gastroenterol 1999;94:3236-8.
3. Halfvarson J, Bodin L, Tysk C, Lindberg E, Jarnerot G. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 2003;124:1767-73.
4. Halfvarson J, Jess T, Bodin L, Jarnerot G, Munkholm P, Binder V, Tysk C. Longitudinal concordance for clinical characteristics in a Swedish-Danish twin population with inflammatory bowel disease. Inflamm Bowel Dis 2007;13:1536-44.
5. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006;314:1461-3.
6. D'Amato M, Bruce S, Bresso F, Zucchelli M, Ezer S, Pulkkinen V, Lindgren C, Astegiano M, Rizzetto M, Gionchetti P, Riegler G, Sostegni R, et al. Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease. Gastroenterology 2007;133:808-17.
7. De Jager PL, Franchimont D, Waliszewska A, Bitton A, Cohen A, Langelier D, Belaiche J, Vermeire S, Farwell L, Goris A, Libioulle C, Jani N, et al. The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun 2007;8:387-97.
8. Hemminki K, Li X, Sundquist K, Sundquist J. Do inflammatory bowel disease and cancer share susceptibility: a family study. Inflamm Bowel Dis, in press.
9. Mellemkjaer L, Olsen JH, Frisch M, Johansen C, Gridley G, McLaughlin JK. Cancer in patients with ulcerative colitis. Int J Cancer 1995;60:330-3.
10. Karlen P, Löfberg R, Broström O, Leijonmarck C, Hellers G, Persson P. Increased risk of cancer in ulcerative colitis: a population-based study Am J Gastroenterol 1999;94:1047-52.
11. Askling J, Brandt L, Lapidus A, Karlen P, Bjorkholm M, Lofberg R, Ekbom A. Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut 2005;54:617-22.
12. Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 2001;91:854-62.
13. Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Feltelius N, Coster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapaa-Dahlqvist S, et al. Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists. Ann Rheum Dis 2005;64:1421-6.
14. Landgren O, Engels EA, Caporaso NE, Gridley G, Mellemkjaer L, Hemminki K, Linet MS, Goldin LR. Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries. Blood 2006;108:292-6.
15. Landgren O, Linet MS, McMaster ML, Gridley G, Hemminki K, Goldin LR. Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study. Int J Cancer 2006;118:3095-98.
16. Landgren O, Engels EA, Pfeiffer RM, Gridley G, Mellemkjaer L, Olsen JH, Kerstann KF, Wheeler W, Hemminki K, Linet MS, Goldin LR. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst 2006;98:1321-30.
17. Birkeland S, Storm H, Lamm L, Barlow L, Blohme L, Forsberg B, Eklund B, Fjeldbord O, Friedberg M, Frödin L, Glattre E, Halvorsen S, et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 1995;60:183-9.
18. Vajdic CM, McDonald SP, McCredie MR, van Leeuwen MT, Stewart JH, Law M, Chapman JR, Webster AC, Kaldor JM, Grulich AE. Cancer incidence before and after kidney transplantation. JAMA 2006;296:2823-31.
19. van Staa TP, Card T, Logan RF, Leufkens HG. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut 2005;54:1573-8.
20. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007;369:1641-57.
21. Wolfe F, Michaud K. Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study. Arthritis Rheum 2007;56:2886-95.
22. Blomqvist P, Feltelius N, Lofberg R, Ekbom A. A 10-year survey of inflammatory bowel diseases-drug therapy, costs and adverse reactions. Aliment Pharmacol Ther 2001;15:475-81.
23. Askling J. Malignancy and rheumatoid arthritis. Curr Rheumat Rep 2007;9:421-6.
24. Centre for Epidemiology. Cancer incidence in Sweden 2005. Stockholm: The National Board of Health and Welfare, 2007.
25. von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP. The risk of cancer in patients with Crohn's disease. Dis Colon Rectum 2007;50:839-55.
26. Hemminki K, Li X, Sundquist K, Sundquist J. Cancer risk in hospitalized rheumatoid arthritis patients. Rheumatology (Oxford), in press.